Answering questions and challenges in the management of health smoking and COPD patients

URIBE ECHEVERRIA E. M.; VERGARA S; ALVAREZ R.; -MONESTEROLO N., SANTANDER V., NIGRA A.; AMAIDEN M., RIVELLI J., CASALE C.

Congreso; European Respiratory Society (ERS) International Congress; 2020

GOLD defined COPD as a preventable disease and suggest therapeutic strategy, so the aim of this studywas to identify the best method of cellular biomarker to help an assessment of smokers patients, to earlydiagnosis, prevent of the disease and choose the specific therapy for COPD patients. We analyzed thesputum differential cell phenotype of healthy ex-smoking (HS 33) and patients with COPD (85) according toGOLD A (19) B (29) C (19) D (18). Eosinophils count from blood and sputum were correlated andcompared the FEV1 within 1 year in the HS group. The population included female (47) and male (71) (NS).Age, P/ Y and FEV1% post BD were statistically significant between HS and COPD patients (p